Bristol Myers to Acquire the Drugmaker Karuna for $14 Billion
The deal is a bet on the growing market for psychiatric and neurological drugs.
from NYT > Health https://ift.tt/5iz4B3Q
via IFTTT
from NYT > Health https://ift.tt/5iz4B3Q
via IFTTT
Subscribe to:
Post Comments
(
Atom
)
Why Drug Companies Are Rushing to Market Ketamine Medicines
Spurred on by the Trump administration’s embrace of psychedelic medicine, researchers are experimenting with new — and not so new — forms of...
No comments